PIK3CA Mutational Status Assessment

NCT06706570 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-03-24

No results posted yet for this study

Summary

Evaluation of PIK3CA mutational status: a route towards a tailored diagnostic approach.

Conditions

  • Breast Cancer Metastatic

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Nicola Fusco, MD · Istituto Europeo di Oncologia

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-06
Primary Completion
2026-12-31
Completion
2030-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06706570 on ClinicalTrials.gov